Why Achillion Pharmaceuticals, Inc. Stock Launched 18% Higher in October

- Home
- TZ Newswire
- Business Features
- ETF's
- Futures
- Options
- Real Estate
- Stocks
- TZ Featured Lists
- TZ Latest News
- TZ Resources
Editorial Archives
Editorial Archives

Published in TZ Latest News 6 November, 2014 by The TZ Newswire Staff

Why Achillion Pharmaceuticals, Inc. Stock Launched 18% Higher in October

Achillion Pharmaceuticals was among the top-performing biotech stocks in October. Find out why Achillion’s shares rallied so convincingly and whether or not it can continue.

See also
- Next Article Currencies: Euro falls to 26-month low against dollar
- Previous Article Did CVS Health Corp. Make the Right Decision When It Stopped Selling Tobacco?
Editorial Calender

November 2014

M T W T F S S

1 2

3 4 5 6 7 8 9

10 11 12 13 14 15 16

17 18 19 20 21 22 23

24 25 26 27 28 29 30

« Oct Dec »
Recent Tags

Abnormal Returns Active management Asia Brave New World Business Chart.ly Chicago Board Options Exchange CNBC Commodities and Futures Covestor Day Trading Derivatives Equities Exchange Exchange-traded fund Funds Gawker.com GDP Gold Gold as an investment Gross domestic product High-frequency trading Hong Kong Investing Japan Market maker May 6 2010 flash crash Mutual fund National Association of Home Builders New York Mercantile Exchange Option S&P 500 SEC Standard & Poor Stock Stocks and Bonds Stock trader StockTwits Timothy Sykes Tokyo Trade Twitter U.S. Dollar Index U.S. Securities and Exchange Commission United States dollar

The Traderszone Network

Editorial Archives

Published in TZ Latest News 6 November, 2014 by The TZ Newswire Staff

Why Achillion Pharmaceuticals, Inc. Stock Launched 18% Higher in October

See also

Editorial Calender

Recent Tags